4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-038865
Options or other derivatives
- Director acquired 23,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Anderson Kenneth Carl Director | 2022-06-22 | Grant or award · Stock Option (Right to Buy) | +23,500 | 23,500 | D | ||
Loading xslF345X03/doc4.xml…